Gerald Clarke | 11/02/2013
Artemisinin is a front line anti-malarial drug which was derived from the sweet wormwood plant. ‘Growing on trees’ however, isn’t all it’s cracked up to be and the supply could be unpredictable. Professor Jay Keasling, using synthetic biology techniques, had grown his own artemisinin in the lab and with support from the Bill and Melinda Gates Foundation and Sanofi, the industrial-scale “brewing” of artemisinin now promises to be the first successful ap...
To continue reading this story Click Here
RECOMMENDED
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More